PET Drugmaker Warned for Unclean Conditions and Bacterial Contamination

Drug Industry Daily
A A
The FDA hit N-Molecular, doing business as SOFIE, with a warning letter after an inspection of the company’s positron emission tomography (PET) drug manufacturing facility in Haverhill, Mass., brought to light numerous hygiene violations.

To View This Article:

Login

Subscribe To Drug Industry Daily